학술논문

BCL2A1 is a potential biomarker for postoperative seizure control in patients with low-grade gliomas
Document Type
Article
Source
In: CNS Neuroscience and Therapeutics. (CNS Neuroscience and Therapeutics, November 2013, 19(11):882-888)
Subject
Language
English
ISSN
17555930
17555949